High-Dose Rate Brachytherapy Alone for Treatment of Unfavorable Intermediate Risk Prostate Cancer: A Propensity-Score Matched Analysis

E.Y. Liu,E.Y. Lin,A. Lee, P.S. Venkat, J.C. Shiao, A. Wong, A. Yu, M.A. Hagio,S.J. Park, J. Demanes,A.J. Chang

International journal of radiation oncology, biology, physics（2023）

引用 0|浏览3

暂无评分

摘要

This propensity-score matched study demonstrates the feasibility of HDR BT alone for effective treatment of UIR prostate cancer when compared to HDR+EBRT or HDR+EBRT+ADT, while potentially minimizing the added toxicities of EBRT and the undesirable side effect profile of ADT.

查看译文

关键词

risk prostate cancer,prostate cancer,high-dose,propensity-score

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要